在SARS-CoV-2 mRNA疫苗接种地点生长的皮洛马特里科马
Merve Hatun Erkayman1, Melike Güven1, Merve Bingöl1,2
1From the Department of Dermatology and Venereology, Ataturk University, Erzurum, Türkiye.
Indian journal of dermatology
|December 15, 2023
概括
一种罕见的皮肤瘤pilomatricoma可能与BNT162b2 mRNA COVID-19疫苗有关. 这一案例凸显了疫苗接种和皮洛马特里科马的发展之间的潜在联系,可能是由于炎症引起的.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 皮洛马特里科马是一种良性皮肤瘤,通常发生在儿童和青少年身上.
- 皮洛马特里科马的病因因素包括创伤和疫苗接种.
- BNT162b2 mRNA疫苗被广泛用于COVID-19的预防.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376


